Showing results (171-180 of 218) with videos related to

Sort By:
Pageof 22
World Journal of Urology|March 31, 2015
The use of hemostatic agents does not prevent hemorrhagic complications of robotic partial nephrectomyBenoit Peyronnet, Emmanuel Oger, Zineddine Khene, et al.
World Journal of Urology|August 31, 2013
Nomograms to predict late urinary toxicity after prostate cancer radiotherapyRomain Mathieu, Juan David Ospina Arango, Véronique Beckendorf, et al.
Urologic Oncology|February 11, 2020
Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaborationFrancesco Soria, Andrea Giordano, David D'Andrea, et al.
Urologia Internationalis|February 24, 2021
Complete Transurethral Resection before Radical Cystectomy May Improve Oncological OutcomesVivien Graffeille, Grégory Verhoest, Alexandre Gryn, et al.
Clinical Genitourinary Cancer|March 7, 2019
Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 ExpressionSolène-Florence Kammerer-Jacquet, Angelique Brunot, Mathilde Lefort, et al.
Histopathology|May 14, 2022
Comprehensive study of nine novel cases of TFEB-amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expressionSolène-Florence Kammerer-Jacquet, Camille Gandon, Frederic Dugay, et al.
Urologic Oncology|June 17, 2017
Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatmentSolène-Florence Kammerer-Jacquet, Angelique Brunot, Karim Bensalah, et al.
European Urology Focus|July 21, 2017
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysisIlaria Lucca, Patrice Jichlinski, Shahrokh F Shariat, et al.
World Journal of Urology|December 18, 2016
Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomyJean Baptiste Beauval, Guillaume Ploussard, Bastien Cabarrou, et al.
Targeted Oncology|May 28, 2017
Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line TherapySolène-Florence Kammerer-Jacquet, Sarah Medane, Karim Bensalah, et al.
Pageof 22